| High-density mapping of the MHC identifies a shared role for HLA-DRB1* 01: 03 in inflammatory bowel diseases and heterozygous advantage in ulcerative colitis P Goyette, G Boucher, D Mallon, E Ellinghaus, L Jostins, H Huang, ... Nature genetics 47 (2), 172-179, 2015 | 360 | 2015 |
| Observations on the ex situ perfusion of livers for transplantation CJE Watson, V Kosmoliaptsis, C Pley, L Randle, C Fear, K Crick, ... American journal of transplantation 18 (8), 2005-2020, 2018 | 339 | 2018 |
| Normothermic perfusion in the assessment and preservation of declined livers before transplantation: hyperoxia and vasoplegia—important lessons from the first 12 cases CJE Watson, V Kosmoliaptsis, LV Randle, AE Gimson, R Brais, JR Klinck, ... Transplantation 101 (5), 1084-1098, 2017 | 231 | 2017 |
| Colorectal liver metastases: Current management and future perspectives J Martin, A Petrillo, EC Smyth, N Shaida, S Khwaja, HK Cheow, ... World Journal of Clinical Oncology 11 (10), 761, 2020 | 198 | 2020 |
| HLA-DR/DQ molecular mismatch: a prognostic biomarker for primary alloimmunity C Wiebe, V Kosmoliaptsis, D Pochinco, IW Gibson, J Ho, PE Birk, ... American journal of transplantation 19 (6), 1708-1719, 2019 | 182 | 2019 |
| HLA class I allelic sequence and conformation regulate leukocyte Ig-like receptor binding DC Jones, V Kosmoliaptsis, R Apps, N Lapaque, I Smith, A Kono, ... The Journal of Immunology 186 (5), 2990-2997, 2011 | 149 | 2011 |
| TCR meta-clonotypes for biomarker discovery with tcrdist3 enabled identification of public, HLA-restricted clusters of SARS-CoV-2 TCRs K Mayer-Blackwell, S Schattgen, L Cohen-Lavi, JC Crawford, A Souquette, ... elife 10, e68605, 2021 | 138 | 2021 |
| Alloantibody responses after renal transplant failure can be better predicted by donor–recipient HLA amino acid sequence and physicochemical disparities than conventional HLA … V Kosmoliaptsis, DH Mallon, Y Chen, EM Bolton, JA Bradley, CJ Taylor American journal of transplantation 16 (7), 2139-2147, 2016 | 129 | 2016 |
| Preimplant normothermic liver perfusion of a suboptimal liver donated after circulatory death CJE Watson, V Kosmoliaptsis, LV Randle, NK Russell, WJH Griffiths, ... American Journal of Transplantation 16 (1), 353-357, 2016 | 128 | 2016 |
| Predicting HLA class II alloantigen immunogenicity from the number and physiochemical properties of amino acid polymorphisms V Kosmoliaptsis, LD Sharples, AN Chaudhry, DJ Halsall, JA Bradley, ... Transplantation 91 (2), 183-190, 2011 | 115 | 2011 |
| A comparison of HLA molecular mismatch methods to determine HLA immunogenicity C Wiebe, V Kosmoliaptsis, D Pochinco, CJ Taylor, P Nickerson Transplantation 102 (8), 1338-1343, 2018 | 108 | 2018 |
| Liver transplantation outcomes from controlled circulatory death donors: SCS vs in situ NRP vs ex situ NMP R Gaurav, AJ Butler, V Kosmoliaptsis, L Mumford, C Fear, L Swift, ... Annals of Surgery 275 (6), 1156-1164, 2022 | 106 | 2022 |
| Predicting HLA class I alloantigen immunogenicity from the number and physiochemical properties of amino acid polymorphisms V Kosmoliaptsis, AN Chaudhry, LD Sharples, DJ Halsall, TR Dafforn, ... Transplantation 88 (6), 791-798, 2009 | 106 | 2009 |
| Detection of immunoglobulin G human leukocyte antigen-specific alloantibodies in renal transplant patients using single-antigen-beads is compromised by the presence of … V Kosmoliaptsis, JA Bradley, S Peacock, AN Chaudhry, CJ Taylor Transplantation 87 (6), 813-820, 2009 | 104 | 2009 |
| Back to the future: application of contemporary technology to long-standing questions about the clinical relevance of human leukocyte antigen-specific alloantibodies in renal … CJ Taylor, V Kosmoliaptsis, DM Summers, JA Bradley Human immunology 70 (8), 563-568, 2009 | 90 | 2009 |
| Impact of donor mismatches at individual HLA-A,-B,-C,-DR, and-DQ loci on the development of HLA-specific antibodies in patients listed for repeat renal transplantation V Kosmoliaptsis, O Gjorgjimajkoska, LD Sharples, AN Chaudhry, ... Kidney international 86 (5), 1039-1048, 2014 | 87 | 2014 |
| Sensitization in transplantation: assessment of risk (STAR) 2019 working group meeting report AR Tambur, P Campbell, AS Chong, S Feng, ML Ford, H Gebel, RG Gill, ... American Journal of Transplantation 20 (10), 2652-2668, 2020 | 84 | 2020 |
| Ten-year experience of selective omission of the pretransplant crossmatch test in deceased donor kidney transplantation CJ Taylor, V Kosmoliaptsis, LD Sharples, D Prezzi, CH Morgan, T Key, ... Transplantation 89 (2), 185-193, 2010 | 80 | 2010 |
| Predicting the immunogenicity of human leukocyte antigen class I alloantigens using structural epitope analysis determined by HLAMatchmaker V Kosmoliaptsis, JA Bradley, LD Sharples, A Chaudhry, T Key, ... Transplantation 85 (12), 1817-1825, 2008 | 78 | 2008 |
| Electrostatic modifications of the human leukocyte antigen‐DR P9 peptide‐binding pocket and susceptibility to primary sclerosing cholangitis JR Hov, V Kosmoliaptsis, JA Traherne, M Olsson, KM Boberg, A Bergquist, ... Hepatology 53 (6), 1967-1976, 2011 | 73 | 2011 |
